Pathological interactions with the timing of birth and uterine activation

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 47, Issue 6, 2007, Pages 430-437

  Smith, Roger ^a   Van Helden, Dirk ^b   Hirst, Jon ^a   Zakar, Tamas ^a   Read, Mark ^a   Chan, Eng Cheng ^a   Palliser, Hannah ^a   Grammatopoulos, Dimitris ^c   Nicholson, Richard ^a   Parkington, Helena C ^d  

^a JOHN HUNTER HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Parturition; Preterm birth; Tocolytics

Indexed keywords

ADALIMUMAB; ADENYLATE CYCLASE; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; ETANERCEPT; GESTAGEN; HORMONE ANTAGONIST; HYDROCORTISONE; INFLIXIMAB; MIFEPRISTONE; PHOSPHOLIPASE C; PRASTERONE SULFATE; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; THG 113; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UTERUS SPASMOLYTIC AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DNA BINDING; ENZYME INHIBITION; FETUS CIRCULATION; FETUS DISEASE; HORMONE RELEASE; HUMAN; HYDROCORTISONE RELEASE; LABOR; MATERNAL STRESS; MYOMETRIUM; NONHUMAN; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; SYNCYTIOTROPHOBLAST; TOCOLYSIS; TREATMENT PLANNING; TWIN PREGNANCY; UTERUS CONTRACTION;

CERVIX UTERI; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; LABOR, OBSTETRIC; MYOMETRIUM; PARTURITION; PREGNANCY; PREMATURE BIRTH; TOCOLYTIC AGENTS; UTERINE CONTRACTION;

EID: 35948968894     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2007.00775.x     Document Type: Review

References (67)

1. Patel RR, Steer P, Doyle P, Little MP, Elliott P. Does gestation vary by ethnic group? A London-based study of over 122 000 pregnancies with spontaneous onset of labour. Int J Epidemiol 2004 33 : 107 113.
2. Liggins GC, Fairclough RJ, Grieves SA, Kendall JZ, Knox BS. The mechanism of initiation of parturition in the ewe. Recent Prog Horm Res 1973 29 : 111 159.
3. Ford MM, Young IR, Caddy DJ, Thorburn GD. Fetal and maternal endocrine changes approaching parturition in the goat: Lack of evidence for prostaglandins E2 and F2alpha as signals for luteolysis. Biol Reprod 1998 58 : 1065 1070.
4. Bowman ME, Lopata A, Jaffe RB, Golos TG, Wickings J, Smith R. Corticotropin-releasing hormone-binding protein in primates. Am J Primatol 2001 53 : 123 130.
5. Smith R, Wickings EJ, Bowman ME et al. Corticotropin-releasing hormone in chimpanzee and gorilla pregnancies. J Clin Endocrinol Metab 1999 84 : 2820 2825.
6. Sasaki A, Liotta AS, Luckey MM, Margioris AN, Suda T, Krieger DT. Immunoreactive corticotropin-releasing factor is present in human maternal plasma during the third trimester of pregnancy. J Clin Endocrinol Metab 1984 59 : 812 814.
7. Goland RS, Wardlaw SL, Stark RI, Brown LS, Jr., Frantz AG. High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy. J Clin Endocrinol Metab 1986 63 : 1199 1203.
8. Wolfe C, Poston L, Jones M. Digoxin-like immunoreactive factor, corticotropin-releasing factor, and pregnancy [letter]. Lancet 1987 1 : 335 336.
9. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy [see comments]. Nat Med 1995 1 : 460 463.
10. Wadhwa PD, Porto M, Garite TJ, Chicz-DeMet A, Sandman CA. Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy. Am J Obstet Gynecol 1998 179 : 1079 1085.
11. Leung TN, Chung TK, Madsen G et al. Analysis of mid-trimester corticotrophin-releasing hormone and alpha-fetoprotein concentrations for predicting pre-eclampsia. Hum Reprod 2000 15 : 1813 1818.
12. Holzman C, Jetton J, Siler-Khodr T, Fisher R, Rip T. Second trimester corticotropin-releasing hormone levels in relation to preterm delivery and ethnicity. Obstet Gynecol 2001 97 : 657 663.
13. Berkowitz GS, Lapinski RH, Lockwood CJ, Florio P, Blackmore-Prince C, Petraglia F. Corticotropin-releasing factor and its binding protein: Maternal serum levels in term and preterm deliveries. Am J Obstet Gynecol 1996 174 : 1477 1483.
14. Emanuel RL, Robinson BG, Seely EW et al. Corticotrophin releasing hormone levels in human plasma and amniotic fluid during gestation. Clin Endocrinol (Oxf) 1994 40 : 257 262.
15. Cheng YH, Nicholson RC, King B, Chan EC, Fitter JT, Smith R. Corticotropin-releasing hormone gene expression in primary placental cells is modulated by cyclic adenosine 3′,5′-monophosphate. J Clin Endocrinol Metab 2000 85 : 1239 1244.
16. Ni X, Nicholson RC, King BR, Chan EC, Read MA, Smith R. Estrogen represses whereas the estrogen-antagonist ICI 182780 stimulates placental CRH gene expression. J Clin Endocrinol Metab 2002 87 : 3774 3778.
17. Ni X, Hou Y, Yang R, Tang X, Smith R, Nicholson RC. Progesterone receptors A and B differentially modulate corticotropin-releasing hormone gene expression through a cAMP regulatory element. Cell Mol Life Sci 2004 61 : 1114 1122.
18. Sandman CA, Glynn L, Schetter CD et al. Elevated maternal cortisol early in pregnancy predicts third trimester levels of placental corticotropin releasing hormone (CRH): Priming the placental clock. Peptides 2006 27 : 1457 1463.
19. Glynn LM, Wadhwa PD, Dunkel-Schetter C, Chicz-Demet A, Sandman CA. When stress happens matters: Effects of earthquake timing on stress responsivity in pregnancy. Am J Obstet Gynecol 2001 184 : 637 642.
20. Warren WB, Goland RS, Wardlaw SL, Stark RI, Fox HE, Conwell IM. Elevated maternal plasma corticotropin releasing hormone levels in twin gestation. J Perinat Med 1990 18 : 39 44.
21. Rouse DJ, Caritis SN, Peaceman AM et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 2007 357 : 454 461.
22. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007 357 : 462 469.
23. McGrath S, McLean M, Smith D, Bisits A, Giles W, Smith R. Maternal plasma corticotropin-releasing hormone trajectories vary depending on the cause of preterm delivery. Am J Obstet Gynecol 2002 186 : 257 260.
24. Giles WB, McLean M, Davies JJ, Smith R. Abnormal umbilical artery Doppler waveforms and cord blood corticotropin-releasing hormone. Obstet Gynecol 1996 87 : 107 11.
25. Goland RS, Jozak S, Warren WB, Conwell IM, Stark RI, Tropper PJ. Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. J Clin Endocrinol Metab 1993 77 : 1174 1179.
26. Korebrits C, Yu DH, Ramirez MM, Marinoni E, Bocking AD, Challis JR. Antenatal glucocorticoid administration increases corticotrophin-releasing hormone in maternal plasma. Br J Obstet Gynaecol 1998 105 : 556 561.
27. Chan EC, Smith R, Lewin T et al. Plasma corticotropin-releasing hormone, beta-endorphin and cortisol inter-relationships during human pregnancy. Acta Endocrinol (Copenh) 1993 128 : 339 344.
28. Jones SA, Challis JR. Steroid, corticotrophin-releasing hormone, ACTH and prostaglandin interactions in the amnion and placenta of early pregnancy in man. J Endocrinol 1990 125 : 153 159.
29. Tsatsanis C, Dermitzaki E, Venihaki M et al. The corticotropin-releasing factor (CRF) family of peptides as local modulators of adrenal function. Cell Mol Life Sci 2007.
30. Grammatopoulos D, Dai Y, Chen J et al. Human corticotropin-releasing hormone receptor: Differences in subtype expression between pregnant and nonpregnant myometria. J Clin Endocrinol Metab 1998 83 : 2539 2544.
31. Smith R, Mesiano S, Chan EC, Brown S, Jaffe RB. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrinol Metab 1998 83 : 2916 2920.
32. Emanuel RL, Torday JS, Asokananthan N, Sunday ME. Direct effects of corticotropin-releasing hormone and thyrotropin-releasing hormone on fetal lung explants. Peptides 2000 21 : 1819 1829.
33. Mesiano S, Chan EC, Fitter JT, Kwek K, Yeo G, Smith R. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab 2002 87 : 2924 2930.
34. Laatikainen TJ, Raisanen IJ, Salminen KR. Corticotropin-releasing hormone in amniotic fluid during gestation and labor and in relation to fetal lung maturation. Am J Obstet Gynecol 1988 159 : 891 895.
35. Allport VC, Pieber D, Slater DM, Newton R, White JO, Bennett PR. Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the 'functional progesterone withdrawal'. Mol Hum Reprod 2001 7 : 581 586.
36. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003 188 : 419 424.
37. Meis PJ, Klebanoff M, Thom E et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003 348 : 2379 2385.
38. Smith R. Parturition. N Engl J Med 2007 356 : 271 283.
39. Challis JR, Lye SJ. Parturition. Oxf Rev Reprod Biol 1986 8 : 61 129.
40. Parkington HC, Harding R, Sigger JN. Co-ordination of electrical activity in the myometrium of pregnant ewes. J Reprod Fertil 1988 82 : 697 705.
41. Nagarajan R, Eswaran H, Wilson JD, Murphy P, Lowery C, Preissl H. Analysis of uterine contractions: a dynamical approach. J Matern Fetal Neonatal Med 2003 14 : 8 21.
42. Young RC, Schumann R, Zhang P. The signaling mechanisms of long distance intercellular calcium waves (far waves) in cultured human uterine myocytes. J Muscle Res Cell Motil 2002 23 : 279 284.
43. Khan RN, Matharoo-Ball B, Arulkumaran S, Ashford ML. Potassium channels in the human myometrium. Exp Physiol 2001 86 : 255 264.
44. Slattery MM, Morrison JJ. Preterm delivery. Lancet 2002 360 : 1489 1497.
45. Bisits AM, Smith R, Mesiano S et al. Inflammatory aetiology of human myometrial activation tested using directed graphs. Plos Comput Biol 2005 1 : 132 136.
46. Phillippe M, Sweet LM, Engle D. The role of phospholipase Cgamma1 tyrosine phosphorylation during phasic myometrial contractions. Am J Obstet Gynecol 2007 196 : 179 e1 179 e7.
47. O'Sullivan CJ, Allen NM, O 'Loughlin AJ, Friel AM, Morrison JJ. Thrombin and PAR1-activating peptide: effects on human uterine contractility in vitro. Am J Obstet Gynecol 2004 190 : 1098 1105.
48. Belt AR, Baldassare JJ, Molnar M, Romero R, Hertelendy F. The nuclear transcription factor NF-κB mediates interleukin-1β-induced expression of cyclooxygenase-2 in human myometrial cells. Am J Obstet Gynecol 1999 181 : 359 366.
49. Inoue H, Tanabe T, Umesono K. Feedback control of cyclooxygenase-2 expression through PPARγ. J Biol Chem 2000 275 : 28028 28032.
50. Allport VC, Pieber D, Slater DM, Newton R, White JO, Bennett PR. Human labour is associated with nuclear factor κΒ activity which mediates cyclo-oxygenase-2 expression and is involved with the 'functional progesterone withdrawal'. Mol Human Reprod 2001 7 : 581 586.
51. Chapman NR, Europe-Finner GN, Robson SC. Expression and deoxyribonucleic acid-binding activity of the nuclear factor κB family in the human myometrium during pregnancy and labor. J Clin Endocrinol Metab 2004 89 : 5683 5693.
52. Lappas M, Permezel M, Georgiou HM, Rice GE. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol Reprod 2002 67 : 668 673.
53. Brodt-Eppley J, Myatt L. Prostaglandin receptors in lower segment myometrium during gestation and labor. Obstet Gynecol 1999 93 : 89 93.
54. 2α receptor antagonist which delays preterm labor. J Soc Gynecol Investig 2001 : 79A.
55. Constancia M, Hemberger M, Hughes J et al. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 2002 417 : 945 948.
56. 2α receptor (FP) antagonism and human uterine contractility in vitro. BJOG: Int J Obstet Gynaecol 2005 112 : 1034 1042.
57. 2α receptor antagonist. Am J Obstet Gynecol 2005 193 : 256 266.
58. Maymon E, Ghezzi F, Edwin SS et al. The tumor necrosis factor alpha and its soluble receptor profile in term and preterm parturition. Am J Obstet Gynecol 1999 181 : 1142 1148.
59. Miralles R, Hodge R, McParland PC et al. Relationship between antenatal inflammation and antenatal infection identified by detection of microbial genes by polymerase chain reaction. Pediatr Res 2005 57 : 570 577.
60. Jacobsson B. Intra-amniotic infection and inflammation in preterm birth - is bacteria always the connection? Commentary on the article by Miralles et al. on page 570. Pediatr Res 2005 57 : 473 474.
61. Miyamura K, Malhotra R, Hoppe HJ et al. Surfactant proteins A (SP-A) and D (SP-D): levels in human amniotic fluid and localization in the fetal membranes. Biochim Biophys Acta 1994 1210 : 303 307.
62. Mendelson CR, Condon JC. New insights into the molecular endocrinology of parturition. J Steroid Biochem Mol Biol 2005 93 : 113 119.
63. Zakar T, Hertelendy F. Regulation of prostaglandin synthesis in the human uterus. J Matern Fetal Med 2001 10 : 223 235.
64. Roux CH, Brocq O, Breuil V, Albert C, Euller-Ziegler L. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy. Rheumatology (Oxford) 2007 46 : 695 698.
65. Wang H, Parry S, Macones G et al. Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM). Hum Mol Genet 2004 13 : 2659 2669.
66. Wang H, Parry S, Macones G et al. A functional SNP in the promoter of the SERPINH1 gene increases risk of preterm premature rupture of membranes in African Americans. Proc Natl Acad Sci USA 2006 103 : 13463 13467.
67. Ferrand PE, Parry S, Sammel M et al. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 2002 8 : 494 501.